Summary:
Given the poor prognosis of patients with advanced cutaneous T-cell lymphoma and the high transplant-related mortality associated with conventional allogeneic bone marrow transplantation, we performed nonmyeloablative transplantation of allogeneic stem cells (ASCT) from HLA-identical siblings in three patients with this disease. All patients achieved full donor engraftment, clearance of clonal T cells leading to durable complete remissions but experienced high incidence of infections, which proved fatal in one case. These results suggest that nonmyeloablative ASCT is a novel and potentially curative therapy for patients with advanced T-cell lymphomas who have a histocompatible sibling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Diamandidou E, Cohen PR, Kurzrock R . Mycosis fungoides and Sézary syndrome. Blood 1996; 88: 2385–2409.
Siegel RS, Pandlfino T, Guitart J et al. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 2000; 18: 2908–2925.
De Coninck EC, Kim YH, Varghese A, Hoppe R . Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. J Clin Oncol 2001; 19: 779–784.
Bigler RD, Crilley P, Micaily B et al. Autologous bone marrow transplantation for advanced stage mycosis fungoides. Bone Marrow Transplant 1991; 7: 133–137.
Sterling JC, Marcus R, Burrows NP, Roberts SO . Erythrodermic mycosis fungoides treated with total body irradiation and autologous bone marrow transplantation. Clin Exp Dermatol 1995; 20: 73–75.
Olavarria E, Child F, Woolford A et al. T-cell depletion and autologous stem cell transplantation in the management of tumor stage mycosis fungoides with peripheral blood involvement. Br J Haematol 2001; 114: 624–631.
Guitart BRK, Traynor A, Link C et al. Allogenic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect. Bone Marrow Transplant 2000; 25: 111–113.
Molina A, Nademanee A, Arber DA, Forman SJ . Remission of refractory Sezary syndrome after bone marrow transplantation from a matched unrelated donor. Biol Blood Marrow Transplant 1999; 5: 400–404.
Molina A, Arber D, Murata-Collins JL et al. Clinical, cytogenetic and molecular remissions after allogeneic hematopoietic stem cell transplantation (HSCT) for refractory Sezary syndrome and tumor-stage mycosis fungoides. Blood 2001; 98: 409a.
Cordell J, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219–229.
Bottaro M, Berti E, Biondi A et al. Heteroduplex analysis of T-cell γ gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994; 83: 3271–3278.
Pindolia K, Janakiraman N, Kasten-Sportes C et al. Enhanced assessment of allogenic bone marrow transplantation using automated fluorescent-based typing. Bone Marrow Transplant 1999; 24: 1235–1241.
Vonderheid EC, Bernengo MG, Burg G et al. Update on the erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 45: 95–105.
Morolleau JP, Bacard M, Flageul B et al. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma. Arch Dermatol 1995; 131: 574–579.
Saleh MN, LeMaistre CF, Kuzel TM et al. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides. J Am Acad Dermatol 1998; 39: 63–73.
Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cyto-reduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756–763.
Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogenic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817.
Scarisbrick JJ, Child FJ, Clift A et al. A trial of fludarabine and cyclophosphamide combination therapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma. Br J Haematol 2001; 144: 1010–1015.
Cooper DL, Braverman IM, Sarris AH et al. Cyclosporine treatment of refractory T-cell lymphomas. Cancer 1993; 71: 2335–2341.
Tsambiras PE, Patel S, Greene JN et al. Infectious complications of cutaneous T-cell lymphoma. Cancer Control 2001; 8: 185–188.
Axelrod PI, Lorber B, Vonderheid EC . Infections complicating mycosis fungoides and Sézary syndrome. JAMA 1992; 267: 1354–1358.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soligo, D., Ibatici, A., Berti, E. et al. Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen. Bone Marrow Transplant 31, 663–666 (2003). https://doi.org/10.1038/sj.bmt.1703872
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703872
Keywords
This article is cited by
-
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma
Annals of Hematology (2018)
-
Cutaneous T-Cell Lymphomas: A Review of New Discoveries and Treatments
Current Treatment Options in Oncology (2012)
-
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion
Bone Marrow Transplantation (2009)
-
Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2008)
-
Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma
Bone Marrow Transplantation (2008)